英文名稱  Anti-ATM

中文名稱  毛細(xì)血管擴張性共濟失調(diào)癥突變蛋白抗體

濃    度  1mg/1ml

規(guī)格  0.1ml/100μg  0.2ml/200μg

抗體來源  Rabbit

克隆類型  polyclonal

交叉反應(yīng)  Human, Mouse, Rat

產(chǎn)品類型  一抗

研究領(lǐng)域  心血管細(xì)胞生物免疫學(xué)細(xì)胞表面分子

蛋白分子量  predicted molecular weight: 370kDa

性    狀  Lyophilized or Liquid

免疫原  KLH conjugated synthetic peptide derived from human ATM (2681-2750aa)

亞    型  IgG

純化方法  affinity purified by Protein A

儲存液  0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

產(chǎn)品應(yīng)用   ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

保存條件  Store at -20 °C for one year.

別    名  ataxia telangiectasia mutated; AT complementation group A; AT complementation group C; AT complementation group D; AT complementation group E; AT mutated; AT protein; AT1; ATA; Ataxia telangiectasia gene mutated in human beings; ATC; ATDC; ATE; ATM; DKFZp781A0353; Human phosphatidylinositol 3 kinase homolog; MGC74674; Serine protein kinase ATM; T cell prolymphocytic leukemia; TEL1; TPLL.